Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.
Adult
COVID-19
/ epidemiology
COVID-19 Vaccines
/ administration & dosage
Cross-Sectional Studies
Female
Health Knowledge, Attitudes, Practice
Health Personnel
/ psychology
Humans
Italy
/ epidemiology
Male
Middle Aged
SARS-CoV-2
/ immunology
Surveys and Questionnaires
Vaccination Refusal
/ psychology
COVID-19
cross-sectional survey
healthcare workers
infectious diseases
vaccine hesitancy
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
26 02 2021
26 02 2021
Historique:
received:
15
01
2021
revised:
19
02
2021
accepted:
23
02
2021
entrez:
3
3
2021
pubmed:
4
3
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) has afflicted tens of millions of people, fostering and unprecedent effort in vaccine development and distribution. Healthcare workers (HCW) play a key role in vaccine promotion and patient guidance, and it is likely that hesitancy among this population will have a major impact on the adoption of a successful immunization policy. To investigate HCW attitudes towards anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccination, we developed an anonymous online cross-sectional survey. 1723 Italian HCW responded. Overall, 1155 (67%) intended to be vaccinated, while 443 (26%) were not sure and 125 (7%) declared refusal. In multivariate analysis, factors associated with hesitancy were using Facebook as the main information source and being a non-physician HCW, while predictors of acceptance included younger age, being in close contact with high-risk groups and having received flu vaccination during the 2019-2020 season. Reasons for hesitancy included lack of trust in vaccine safety (85%) and receiving little (78%) or conflicting (69%) information about vaccines. According to our results, adequate investment in vaccine education for healthcare personnel appears to be urgently needed, prioritizing non-physicians and information quality spread through social media. We hope that our data could help governments and policy-makers to target communication in the ongoing COVID-19 vaccination campaign.
Identifiants
pubmed: 33652829
pii: v13030371
doi: 10.3390/v13030371
pmc: PMC7996832
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Vaccine. 2010 Oct 8;28(43):7030-4
pubmed: 20817011
Emerg Infect Dis. 2019 Jan;25(1):1-4
pubmed: 30560777
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
J Community Health. 2020 Aug;45(4):675-683
pubmed: 32440724
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Euro Surveill. 2019 Jun;24(26):
pubmed: 31266587
JAMA. 2020 Nov 24;324(20):2095-2096
pubmed: 33074293
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
J Infect. 2010 Sep;61(3):252-8
pubmed: 20600304
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
N Engl J Med. 2020 Dec 31;383(27):2677-2678
pubmed: 33301245
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7
pubmed: 25136134
PLoS One. 2020 Sep 3;15(9):e0238414
pubmed: 32881933
JAMA. 2020 Jun 23;323(24):2460-2461
pubmed: 32453392
Lancet. 2011 Aug 6;378(9790):526-35
pubmed: 21664679
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 Feb 18;384(7):e23
pubmed: 33406324